← Back to Search

Behavioral Intervention

Dissonance-Based Obesity Prevention + Response and Attention Training for Obesity (PH Trial)

N/A
Waitlist Available
Led By Eric M Stice, Ph.D.
Research Sponsored by Oregon Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 2 months, 8 months, 14 months, 26 months, and 38 months
Awards & highlights

PH Trial Summary

This trial is testing whether a novel obesity prevention program is more effective when done in single-sex versus mixed-sex groups, and whether adding food response and attention training increases weight gain prevention effects.

Who is the study for?
This trial is for late adolescents with a BMI between 20 and 30 who are moderately to extremely concerned about their weight. It's not open to individuals diagnosed with anorexia, bulimia, or binge eating disorder.Check my eligibility
What is being tested?
The study tests a dissonance-based obesity prevention program in single- vs mixed-sex groups and adds food response and attention training. The goal is to see if these methods can prevent weight gain more effectively.See study design
What are the potential side effects?
Since this isn't a drug trial but rather a behavioral intervention, typical medication side effects aren't expected. Participants may experience discomfort from discussing weight concerns or changing dietary habits.

PH Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 2 months, 8 months, 14 months, 26 months, and 38 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 2 months, 8 months, 14 months, 26 months, and 38 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Body Fat
Secondary outcome measures
Beck Depression Index (BDI)
Eating Disorder Interview (EDDI)
Weight Concerns Scale from the Eating Disorder Examination Questionnaire (EDE-Q)

PH Trial Design

6Treatment groups
Experimental Treatment
Group I: Mixed Group, Generic Response TrainingExperimental Treatment2 Interventions
Participants in this arm will be assigned to receive Project Health in mixed-sex groups and will complete the generic response and attention training intervention.
Group II: Mixed Group, Food Response TrainingExperimental Treatment2 Interventions
Participants in this arm will be assigned to receive Project Health in mixed-sex groups and will complete the food-focused response and attention training intervention.
Group III: Male Group, Generic Response TrainingExperimental Treatment2 Interventions
Participants in this arm will be assigned to receive Project Health in male-only groups and will complete the generic response and attention training intervention.
Group IV: Male Group, Food Response TrainingExperimental Treatment2 Interventions
Participants in this arm will be assigned to receive Project Health in male-only groups and will complete the food-focused response and attention training intervention.
Group V: Female Group, Generic Response TrainingExperimental Treatment2 Interventions
Participants in this arm will be assigned to receive Project Health in female-only groups and will complete the generic response and attention training intervention.
Group VI: Female Group, Food Response TrainingExperimental Treatment2 Interventions
Participants in this arm will be assigned to receive Project Health in female-only groups and will complete the food-focused response and attention training intervention.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Project Health
2012
N/A
~370

Find a Location

Who is running the clinical trial?

Drexel UniversityOTHER
150 Previous Clinical Trials
47,309 Total Patients Enrolled
30 Trials studying Obesity
6,211 Patients Enrolled for Obesity
Oregon Research InstituteLead Sponsor
84 Previous Clinical Trials
65,861 Total Patients Enrolled
9 Trials studying Obesity
2,222 Patients Enrolled for Obesity
Eric M Stice, Ph.D.Principal InvestigatorOregon Research Institute

Media Library

Project Health (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT03710746 — N/A
Obesity Research Study Groups: Mixed Group, Food Response Training, Mixed Group, Generic Response Training, Female Group, Generic Response Training, Male Group, Generic Response Training, Male Group, Food Response Training, Female Group, Food Response Training
Obesity Clinical Trial 2023: Project Health Highlights & Side Effects. Trial Name: NCT03710746 — N/A
Project Health (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03710746 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research endeavor presently admitting new participants?

"Clinicaltrials.gov suggests that this trial is no longer enrolling patients, as the post date of October 8th 2018 and last update on August 8th 2022 indicate. Nevertheless, there are still 1132 clinical trials actively recruiting individuals for participation."

Answered by AI

Are individuals aged 40 or older being integrated into this clinical trial?

"This study is catering to the teenage demographic, requiring all participants be between 17 and 20 years old. Separately, there are 223 trials for patients below 18 and 698 above 65."

Answered by AI

What are the eligibility requirements to participate in this experiment?

"To become a candidate for this trial, potential participants must have obesity and fit into the age range of 17 to 20 years old. As of now, 406 people are being accepted."

Answered by AI
~6 spots leftby Jun 2024